Form 8-K - Current report:
SEC Accession No. 0000950123-08-006902
Filing Date
2008-06-16
Accepted
2008-06-16 11:41:18
Documents
2
Period of Report
2008-06-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K y60757e8vk.htm 8-K 15721
2 EX-3.1: AMENDED AND RESTATED BYLAWS y60757exv3w1.htm EX-3.1 51103
  Complete submission text file 0000950123-08-006902.txt   68857
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Filer) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20117 | Film No.: 08899772
SIC: 2834 Pharmaceutical Preparations